journal article·2017-11-17Open access

Adapted dexamethasone delivery polyethylene oxide and poly(ɛ-caprolactone) construct promote mesenchymal stem cells chondrogenesis

Armaghan Ghiaee, Faeze Pournaqi, Saeid Vakilian, Abdolah Mohammadi-Sangcheshmeh, Abdolreza Ardeshirylajimi

Abstract

Issues associated with tissue transplantation and shortage of donors has always been a concern, whereas tissue engineering has provided the hopeful opportunities. The aim of this study was to investigate the chondrogenic differentiation potential of mesenchymal stem cells (MSCs) in the presence of embedded Dexamethasone into electrospun Poly(ethyleneoxide) nanofibers composited with Poly(ɛ-caprolactone) nanofibers. Electrospun-fabricated scaffolds were characterized by SEM, tensile, contact angle, release profile, MTT assay, and chonderogenic differentiation of stem cells. Results demonstrated Poly(ɛ-caprolactone) properties improved by composite with a Poly(ethyleneoxide). Overall, stem cells seeded on nanofibers content drug showed highest chondrogenic potential in comparison to the other groups.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Mesenchymal stem cell research · Bone Tissue Engineering Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biology, Faculty of Science, East Tehran Branch, Islamic Azad University, Tehran, Iran;

Stem Cell Technology Research Center, Tehran, Iran;

Department of Animal and Poultry Science, College of Aburaihan, University of Tehran, Pakdasht, Iran;

Department of Tissue Engineering and Regenerative Medicine, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

References (26)

Show source-provided references
1. 10.1111/cpr.1215610.1111/cpr.12156 ↗
2. Ardeshirylajimi A · Cell J · 2014 · 16 · 235
3. 10.1016/j.biomaterials.2008.01.03210.1016/j.biomaterials.2008.01.032 ↗
4. 10.1016/j.biotechadv.2010.01.00410.1016/j.biotechadv.2010.01.004 ↗
5. 10.1093/bmb/ldn02510.1093/bmb/ldn025 ↗
6. 10.2519/jospt.2003.33.10.57810.2519/jospt.2003.33.10.578 ↗
7. 10.1146/annurev.matsci.36.011205.12353710.1146/annurev.matsci.36.011205.123537 ↗
8. 10.4155/tde.12.11410.4155/tde.12.114 ↗
9. Guilak F · Biorheology · 2004 · 41 · 389
10. 10.1002/jcp.2456810.1002/jcp.24568 ↗
11. 10.1007/s11095-011-0445-210.1007/s11095-011-0445-2 ↗
12. Karande T · 2008
13. 10.1016/j.biomaterials.2005.01.00210.1016/j.biomaterials.2005.01.002 ↗
14. 10.1205/cherd0619610.1205/cherd06196 ↗
15. 10.1016/j.ejpb.2012.01.01610.1016/j.ejpb.2012.01.016 ↗
16. 10.1182/blood-2007-07-10369710.1182/blood-2007-07-103697 ↗
17. 10.1016/B978-1-78242-301-0.00006-910.1016/B978-1-78242-301-0.00006-9 ↗
18. 10.1093/ejo/cjn11710.1093/ejo/cjn117 ↗
19. 10.1080/1745275080259811710.1080/17452750802598117 ↗
20. 10.1053/jars.2002.3178310.1053/jars.2002.31783 ↗
21. 10.1002/jbm.a.3560310.1002/jbm.a.35603 ↗
22. 10.1002/jbm.a.3320610.1002/jbm.a.33206 ↗
23. 10.1016/j.bjps.2009.10.02810.1016/j.bjps.2009.10.028 ↗
24. 10.1016/S0142-9612(99)00213-610.1016/S0142-9612(99)00213-6 ↗
25. 10.1089/10763270175333764510.1089/107632701753337645 ↗
26. 10.1089/10763270275350300910.1089/107632702753503009 ↗